interactions:
- request:
    body: tool=biocommons.eutils._internal&email=biocommons-dev%40googlegroups.com&retmode=xml&usehistory=y&retmax=250&db=pubmed&id=23121403
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '130'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - python-requests/2.31.0
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi
  response:
    body:
      string: '<?xml version="1.0" ?>

        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January
        2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">

        <PubmedArticleSet>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23121403</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>367</Volume><Issue>21</Issue><PubDate><Year>2012</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>The
        New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Low-dose
        aspirin for preventing recurrent venous thromboembolism.</ArticleTitle><Pagination><StartPage>1979</StartPage><EndPage>1987</EndPage><MedlinePgn>1979-87</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1056/NEJMoa1210384</ELocationID><Abstract><AbstractText
        Label="BACKGROUND" NlmCategory="BACKGROUND">Patients who have had a first
        episode of unprovoked venous thromboembolism have a high risk of recurrence
        after anticoagulants are discontinued. Aspirin may be effective in preventing
        a recurrence of venous thromboembolism.</AbstractText><AbstractText Label="METHODS"
        NlmCategory="METHODS">We randomly assigned 822 patients who had completed
        initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism
        to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years.
        The primary outcome was a recurrence of venous thromboembolism.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">During a median follow-up period of
        37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned
        to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs.
        4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI],
        0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary
        composite outcomes: the rate of venous thromboembolism, myocardial infarction,
        stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year
        with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66;
        95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial
        infarction, stroke, major bleeding, or death from any cause was reduced by
        33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant
        between-group difference in the rates of major or clinically relevant nonmajor
        bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with
        aspirin, P=0.22) or serious adverse events.</AbstractText><AbstractText Label="CONCLUSIONS"
        NlmCategory="CONCLUSIONS">In this study, aspirin, as compared with placebo,
        did not significantly reduce the rate of recurrence of venous thromboembolism
        but resulted in a significant reduction in the rate of major vascular events,
        with improved net clinical benefit. These results substantiate earlier evidence
        of a therapeutic benefit of aspirin when it is given to patients after initial
        anticoagulant therapy for a first episode of unprovoked venous thromboembolism.
        (Funded by National Health and Medical Research Council [Australia] and others;
        Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Brighton</LastName><ForeName>Timothy
        A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department
        of Haematology, South Eastern Area Laboratory Services (SEALS), Prince of
        Wales Hospital, Sydney, Australia. aspire@ctc.usyd.edu.au</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John W</ForeName><Initials>JW</Initials></Author><Author
        ValidYN="Y"><LastName>Mann</LastName><ForeName>Kristy</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Mister</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Gallus</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Ockelford</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Gibbs</LastName><ForeName>Harry</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Hague</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Diaz</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Kirby</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Simes</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><CollectiveName>ASPIRE Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter
        Study</PublicationType><PublicationType UI="D016449">Randomized Controlled
        Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance
        UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="CommentIn"><RefSource>N Engl J Med. 2012 Nov 22;367(21):2039-41</RefSource><PMID
        Version="1">23121404</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat
        Rev Cardiol. 2013 Jan;10(1):4</RefSource><PMID Version="1">23165071</PMID></CommentsCorrections><CommentsCorrections
        RefType="CommentIn"><RefSource>N Engl J Med. 2013 Feb 21;368(8):773</RefSource><PMID
        Version="1">23425172</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N
        Engl J Med. 2013 Feb 21;368(8):772</RefSource><PMID Version="1">23425173</PMID></CommentsCorrections><CommentsCorrections
        RefType="CommentIn"><RefSource>N Engl J Med. 2013 Feb 21;368(8):772-3</RefSource><PMID
        Version="1">23425174</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch
        Med Wochenschr. 2013 Feb;138(6):244</RefSource><PMID Version="1">23479792</PMID></CommentsCorrections><CommentsCorrections
        RefType="CommentIn"><RefSource>Ann Intern Med. 2013 Mar 19;158(6):JC2</RefSource><PMID
        Version="1">23552619</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Rev
        Clin Esp (Barc). 2013 May;213(4):212</RefSource><PMID Version="1">23814790</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453"
        MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName
        UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517"
        MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator
        ValidYN="Y"><LastName>Brighton</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hague</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Kirby</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mister</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Simes</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gallus</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Ockelford</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Baker</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gibbs</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Coughlin</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Xavier</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Diaz</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Agnelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gibbs</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Karplus</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Fletcher</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>van Rij</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Rogers</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hayward</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Young</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Crispin</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Slade</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Ward</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Tadayon</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Koutts</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Fisher</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Brighton</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>McCardie</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Bianchi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Trinh</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Joseph</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Plenge</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Chong</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Davidson</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Waites</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Cahill</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Tiley</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Lacey</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Jackson</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Boys</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Seldon</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gambrill</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Nandurkar</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Worland</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Salem</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gollogly</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Campbell</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Marshall</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hamilton</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Goss</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Salem</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Poulton</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Jackson</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>de Man</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gan</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Cummins</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Leyden</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sturtz</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Kubler</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sansome</LastName><ForeName>X</ForeName><Initials>X</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>McCann</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Downey</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Carroll</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Duroux</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hamwood</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Styles</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Buckmaster</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Schmidt</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Colquhoun</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Jardim</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gallus</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Osmond</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Jeffries</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Trezona</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>McRae</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>King</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Baker</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Courtley</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Kimber</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Oliver</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>MacDonald</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Shepherd</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Ockelford</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hulton</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Royle</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Haycock</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Simpson</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Yap</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Baker</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>McQuilkin</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Carter</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Body</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Heng</LastName><ForeName>L Lai</ForeName><Initials>LL</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Tan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Tay</LastName><ForeName>J Chin</ForeName><Initials>JC</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Zou</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Pandharpurkar</LastName><ForeName>H Kumar</ForeName><Initials>HK</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>G</LastName><ForeName>Remya</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Stephen</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Benjamin</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Desai</LastName><ForeName>S C</ForeName><Initials>SC</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Singh</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Suresh</LastName><ForeName>K R</ForeName><Initials>KR</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>R</LastName><ForeName>Girija K</ForeName><Initials>GK</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Natarajan</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Goel</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gupta</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mishra</LastName><ForeName>B S</ForeName><Initials>BS</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sidhu</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sidhu</LastName><ForeName>R Singh</ForeName><Initials>RS</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Parakh</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Joshi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mahajan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Grover</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Patel</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Kothurkar</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Ranade</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Fedele</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Crist&#xf3;faro</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gelersztein</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Gelersztein</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>A S</ForeName><Initials>AS</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Bowen</LastName><ForeName>L C</ForeName><Initials>LC</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Dur&#xe1;n</LastName><ForeName>R O Garc&#xed;a</ForeName><Initials>RO</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>C&#xe1;mpora</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Ferro</LastName><ForeName>H H&#xe9;ctor</ForeName><Initials>HH</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Casais</LastName><ForeName>M V</ForeName><Initials>MV</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mister</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Kirby</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mann</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Van Holst Pellekaan</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Chinchen</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Lucas</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Hague</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Simes</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Xavier</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Pais</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Sigamani</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Mathur</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>M</LastName><ForeName>Anupama</ForeName><Initials>A</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>B</LastName><ForeName>Deepthi K</ForeName><Initials>DK</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Diaz</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Chacon</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator
        ValidYN="Y"><LastName>Rucci</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23121403</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1210384</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Fri, 12 Apr 2024 19:08:03 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - D0BD7751F4CB6ED500002C413B201D6D.1.1.m_5
      NCBI-SID:
      - 7413B8DF2690DF14_AE65SID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=7413B8DF2690DF14_AE65SID; domain=.nih.gov; path=/; expires=Sat, 12
        Apr 2025 19:08:04 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '3'
      X-RateLimit-Remaining:
      - '1'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
version: 1
